Since aspirin is now proven to improve stroke outcomes when administered as an antiplatelet in acute therapy for stroke, it may be argued that ACE inhibition/AT1RA blockade may have similar benefits through their actions on thrombus formation; fibrinolysis, plaque stabilization, and collateral circulation enhancement. The gene discussed is ACE; the disease is Stroke.